Pierre Vaudaux Selected Research

Culture Diffusion Chambers

7/2009	Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.
4/2006	Evaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.
9/2005	Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
8/2004	Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.
7/2003	Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus.
3/2003	Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis.
5/2002	Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Vaudaux Research Topics

Disease

19	Infections 04/2015 - 05/2002
7	Foreign Bodies (Foreign Body) 07/2009 - 05/2002
3	Arthritis (Polyarthritis) 04/2015 - 12/2011
2	Staphylococcal Infections 08/2013 - 05/2006
2	Sepsis (Septicemia) 03/2012 - 04/2006
2	Osteomyelitis 12/2011 - 09/2003
1	Infectious Arthritis (Septic Arthritis) 06/2014
1	Gout 06/2014
1	Reinfection 03/2012
1	Hypersensitivity (Allergy) 01/2008
1	Peripheral Arterial Occlusive Disease 1 01/2008
1	Eosinophilia 01/2008
1	Exanthema (Rash) 01/2008
1	Fever (Fevers) 01/2008
1	Wound Infection (Wound Infections) 01/2008
1	Drug Hypersensitivity Syndrome 01/2008
1	Autolysis 09/2006
1	Endocarditis 05/2005
1	Wounds and Injuries (Trauma) 09/2003
1	Body Weight (Weight, Body) 05/2002

Drug/Important Bio-Agent (IBA)

8	Vancomycin FDA LinkGeneric 03/2012 - 05/2002
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2015 - 02/2004
4	GlycopeptidesIBA 07/2013 - 09/2003
3	Daptomycin FDA Link 07/2013 - 07/2003
3	TeicoplaninIBA 03/2012 - 08/2004
2	Methicillin (Metin)FDA Link 08/2013 - 07/2009
2	Rifampin (Rifampicin)FDA LinkGeneric 07/2013 - 12/2011
2	ProdrugsIBA 09/2005 - 05/2002
2	Fibronectins (Fibronectin)IBA 05/2005 - 08/2004
1	Coloring Agents (Dyes)IBA 06/2014
1	Acridine OrangeIBA 06/2014
1	CoagulaseIBA 08/2013
1	Clindamycin (Cleocin)FDA LinkGeneric 12/2011
1	Tigecycline (Tygacil)FDA Link 07/2009
1	Pharmaceutical PreparationsIBA 01/2008
1	ultra-high molecular weight polyethylene (UHMWPE)IBA 04/2007
1	Staphylococcus aureus RNAIIIIBA 09/2006
1	Cephalosporins (Cephalosporin Antibiotics)IBA 05/2006
1	Penicillins (Penicillin)FDA Link 05/2006
1	Anti-Infective Agents (Microbicides)IBA 05/2006
1	Oxacillin (Prostaphlin)FDA LinkGeneric 04/2006
1	ceftobiprole medocarilIBA 09/2005
1	ceftobiproleIBA 09/2005
1	bacterial fibronectin-binding proteinsIBA 05/2005
1	factor AIBA 05/2005
1	Fibrinogen (Factor I)FDA Link 05/2005
1	Carrier Proteins (Binding Protein)IBA 08/2004
1	trovafloxacinIBA 05/2002
1	FluoroquinolonesIBA 05/2002
1	alatrofloxacin (Trovan)FDA Link 05/2002
1	QuinolonesIBA 05/2002
1	Levofloxacin (Levaquin)FDA Link 05/2002

Therapy/Procedure

12	Therapeutics 03/2015 - 05/2002
7	Culture Diffusion Chambers 07/2009 - 05/2002
4	Arthroplasty 04/2015 - 12/2011
2	Debridement 03/2015 - 08/2013
1	Surgical Amputation (Amputations) 01/2008
1	Orthopedic Procedures 05/2006
1	Catheters 04/2006